Amneal Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of AMRX for the last quarter is 659.19 M USD, and it's 6.84% higher compared to the previous quarter. The net income of Q1 24 is -91.64 M USD.